-
SCPH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
scPharmaceuticals (SCPH)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 91.48 mm | 91.48 mm | 91.48 mm | 91.48 mm | 91.48 mm | 91.48 mm |
Cash burn (monthly) | (no burn) | (no burn) | 6.05 mm | 5.31 mm | 5.81 mm | 5.88 mm |
Cash used (since last report) | n/a | n/a | 25.76 mm | 22.61 mm | 24.74 mm | 25.03 mm |
Cash remaining | n/a | n/a | 65.72 mm | 68.88 mm | 66.75 mm | 66.46 mm |
Runway (months of cash) | n/a | n/a | 10.9 | 13.0 | 11.5 | 11.3 |
13F holders | Current |
---|---|
Total holders | 97 |
Opened positions | 26 |
Closed positions | 8 |
Increased positions | 34 |
Reduced positions | 21 |
13F shares | Current |
---|---|
Total value | 164.43 bn |
Total shares | 44.23 mm |
Total puts | 12.10 k |
Total calls | 110.10 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 6.06 mm | $27.63 bn |
Rubric Capital Management | 4.78 mm | $21.77 bn |
AIGH Capital Management | 4.12 mm | $18.81 bn |
Hirschman Orin | 3.11 mm | $0.00 |
Lundbeckfond Invest A/S | 2.86 mm | $12.77 mm |
King Luther Capital Management | 2.23 mm | $10.15 bn |
Suvretta Capital Management | 2.05 mm | $9.34 bn |
BlackRock | 1.85 mm | $8.45 bn |
Vanguard | 1.71 mm | $7.79 bn |
J. Goldman & Co | 1.38 mm | $6.29 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 25 | Tucker John H | Common Stock | Payment of exercise | Dispose F | No | Yes | 3.5587 | 13,360 | 47.54 k | 240,847 |
3 Jan 25 | Rachael Nokes | Common Stock | Payment of exercise | Dispose F | No | Yes | 3.5587 | 5,235 | 18.63 k | 67,616 |
26 Aug 24 | Schaeffer Leonard D | Common Stock | Option exercise | Acquire M | No | No | 3.37 | 6,124 | 20.64 k | 54,451 |
26 Aug 24 | Schaeffer Leonard D | Common Stock | Option exercise | Acquire M | No | No | 1.66 | 5,223 | 8.67 k | 48,327 |
26 Aug 24 | Schaeffer Leonard D | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.37 | 6,124 | 20.64 k | 0 |
26 Aug 24 | Schaeffer Leonard D | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.66 | 5,223 | 8.67 k | 0 |
13 Aug 24 | Orbimed Advisors | Common Stock | Buy | Acquire P | Yes | No | 4 | 21,658 | 86.63 k | 252,858 |
13 Aug 24 | Orbimed Advisors | Common Stock | Buy | Acquire P | Yes | No | 4 | 478,342 | 1.91 mm | 5,806,670 |
6 Aug 24 | Rachael Nokes | Common Stock | Option exercise | Acquire M | No | No | 0 | 10,445 | 0.00 | 72,851 |
6 Aug 24 | Rachael Nokes | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.66 | 10,445 | 17.34 k | 0 |